Sonoma Pharmaceuticals
SNOA
#10401
Rank
HK$48.39 M
Marketcap
HK$28.45
Share price
-3.44%
Change (1 day)
41.62%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -HK$24.33 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are HK$16.93 Million. In 2024 the company made an earning of -HK$34.79 Million a decrease over its 2023 earnings that were of -HK$34.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$24.33 Million-30.07%
2024 -HK$34.79 Million0.54%
2023 -HK$34.6 Million-31.5%
2022 -HK$50.51 Million16.86%
2021 -HK$43.23 Million194.32%
2020 -HK$14.69 Million-58.76%
2019 -HK$35.61 Million-65.66%
2018 -HK$0.11 Billion4.84%
2017 -HK$98.92 Million-2.17%
2016 -HK$0.11 Billion32.12%
2015 -HK$76.53 Million-307.74%
2014 HK$36.83 M-197.5%
2013 -HK$37.78 Million
2010 -HK$59.04 Million-14.02%
2009 -HK$68.67 Million-57.28%
2008 -HK$0.17 Billion-8.03%
2007 -HK$0.18 Billion3.85%
2006 -HK$0.17 Billion39.31%
2005 -HK$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-HK$0.15 Billion 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA